RDX and ovarian cancer: The treatment of ovarian cancer cells with LPA also promotes O-GlcNAcylation of ezrin–radixin–moesin (ERM) cytoskeletal proteins [78], and although the exact mechanism is not entirely understood, LPA-induced activation of ERM suggests the role of LPA in the adhesion and migration of ovarian cancer cells.